Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Succinimidyl-1,2-di-O-hexadecyl-rac-glyceryl carbonate | Succinimidyl-1,2-di-O-hexadecyl-rac-glyceryl carbonate. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg. US Biological Life Sciences. |  Worldwide |
| Succinimidyl-(1-pyrenyl)butyrate 99+% | Succinimidyl-(1-pyrenyl)butyrate 99+%. Group: Biochemicals. Grades: Reagent Grade. CAS No. 114932-60-4,97427-71-9. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-2,2,2-trichloroethyl carbonate | Succinimidyl-2,2,2-trichloroethyl carbonate (CAS# 66065-85-8) is a useful research chemical. Synonyms: Troc-OSu ; N- (2, 2, 2-Trichloroethoxycarbonyloxy) succinimide; MFCD00075216; Troc-OSU, Succinimidyl-2,2,2-trichloroethyl carbonate; AK103676; zlchem 876; 1-{[ (2, 2, 2-Trichloroethoxy) carbonyl]oxy}pyrrolidine-2, 5-dione; 2,5-DIOXOPYRROLIDIN-1-YL 2,2,2-TRICHLOROETHYL CARBONATE. Grades: 95 %. CAS No. 66065-85-8. Molecular formula: C7H6Cl3NO5. Mole weight: 290.49. |  |
| Succinimidyl 2,2,2-trichloroethyl carbonate 99+% (GC) | Succinimidyl 2,2,2-trichloroethyl carbonate 99+% (GC). Group: Biochemicals. Grades: GC. Pack Sizes: 1g, 5g, 25g, 100g. US Biological Life Sciences. | Worldwide |
| Succinimidyl(2R)-6-(tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate | Heterocyclic Organic Compound. Alternative Names: Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate, 1069137-73-0, NPCA, CTK4A4853, ANW-15458, AKOS015855808, AG-L-20258, S0599, (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylic Acid Succinimidyl Ester. CAS No. 1069137-73-0. Molecular formula: C23H29NO7. Mole weight: 431.48. Purity: 0.96. IUPACName: (2,5-dioxopyrrolidin-1-yl) (2R)-2,5,7,8-tetramethyl-6-(oxan-2-yloxy)-3,4-dihydrochromene-2-carboxylate. Canonical SMILES: CC1=C2C (=C (C (=C1C)OC3CCCCO3)C)CCC (O2) (C)C (=O)ON4C (=O)CCC4=O. Catalog: ACM1069137730. |  |
| Succinimidyl-3,5-dimaleimido benzoate | Succinimidyl-3,5-dimaleimido benzoate. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 3- (bromoacetamido) propionate | Succinimidyl 3- (bromoacetamido) propionate. Group: Biochemicals. Alternative Names: SBAP. Grades: Highly Purified. CAS No. 57159-62-3. Pack Sizes: 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 3- (bromoacetamido) propionate 98+% (HPLC) | Succinimidyl 3- (bromoacetamido) propionate 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 3-(tri-n-butylstannyl)benzoate | Succinimidyl 3-(tri-n-butylstannyl)benzoate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]acetate | Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]acetate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 25mg, 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]acetate 99+% | Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]acetate 99+%. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]benzoate | Succinimidyl-4-[2- (tert-butoxycarbonyl) hydrazino]benzoate. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 4-(4-azidophenyl)butyrate | Succinimidyl 4-(4-azidophenyl)butyrate. Group: Biochemicals. Alternative Names: SAPB. Grades: Highly Purified. Pack Sizes: 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 4-(4-azidophenyl)butyrate | Synonyms: SAPB. Grades: ≥ 99% (NMR). CAS No. 441052-82-0. Molecular formula: C14H14N4O4. Mole weight: 302.29. | |
| Succinimidyl 4-(4-azidophenyl)butyrate 99+% (NMR) | Succinimidyl 4-(4-azidophenyl)butyrate 99+% (NMR). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 25mg, 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-azido-2,3,5,6-tetrafluorobenzoate 99+% (NMR) | Succinimidyl-4-azido-2,3,5,6-tetrafluorobenzoate 99+% (NMR). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-hydroxybenzoate | Succinimidyl-4-hydroxybenzoate. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-4-hydroxybenzoate | Succinimidyl-4-hydroxybenzoate. Pack Sizes: Milligram Quantities: 100 mg. Order Number: I106. |  www.prochemonline.com |
| Succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate | Succinimidyl-4-(N-maleimidomethyl) cyclohexane-1-carboxylate. CAS No. 64987-85-5. Pack Sizes: Milligram Quantities: 100 mg. Order Number: CL206. | www.prochemonline.com |
| Succinimidyl 4- (p-maleimidophenyl) butyrate | Succinimidyl 4- (p-maleimidophenyl) butyrate. Group: Biochemicals. Grades: Reagent Grade. CAS No. 79886-55-8. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 4-(p-maleimidophenyl) Butyrate | Succinimidyl 4-(p-maleimidophenyl) Butyrate. Pack Sizes: Milligram Quantities: 100 mg. Order Number: CL200. | www.prochemonline.com |
| Succinimidyl-[4-(psoralen-8-yloxy)]butyrate | Succinimidyl-[4-(psoralen-8-yloxy)]butyrate. Group: Biochemicals. Alternative Names: Spb. Grades: Highly Purified. Pack Sizes: 10mg, 25mg, 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-[4-(psoralen-8-yloxy)]butyrate 99.5+% (NMR) | Succinimidyl-[4-(psoralen-8-yloxy)]butyrate 99.5+% (NMR). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-(4-vinylsulfonyl)benzoate | Succinimidyl- (4-vinylsulfonyl) benzoate. Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl 6-[3- (2-pyridyldithio) propionamido]hexanoate | Succinimidyl 6- [3- (2-pyridyldithio) propionamido] hexanoate. Group: Biochemicals. Alternative Names: N-[6-[ (2, 5-Dioxo-1-pyrrolidinyl) oxy]-6-oxohexyl]-3- (2-pyridinyldithio) propanamide; LC-SPDP. Grades: Highly Purified. CAS No. 158913-22-5. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C18H23N3O5S2. US Biological Life Sciences. | Worldwide |
| Succinimidyl 6-[3-(2-pyridylthio)propionamido] Hexanoate | Succinimidyl 6-[3-(2-pyridylthio)propionamido] Hexanoate. Pack Sizes: Milligram Quantities: 100 mg. Order Number: CL208. | www.prochemonline.com |
| Succinimidyl 6-[ (3-maleimido) propionamido]-hexanoate 99+% | Succinimidyl 6-[ (3-maleimido) propionamido]-hexanoate 99+%. Group: Biochemicals. Grades: Reagent Grade. CAS No. 367927-39-7. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-6-[6- (biotinamido) caproyl]caproylate | Succinimidyl-6-[6- (biotinamido) caproyl]caproylate. Group: Biochemicals. Alternative Names: N-Biotinyl caproyl aminocaproyl N-hydroxysuccinimide 6- (biotinamide caproylamide ) caproic acid N-succinimide ester6-{6-[5-(2-oxo-hexahydro-thieno[3,4-d]imidazol-6-yl)-pentanoylamino]-hexanoylamino}-hexanoic acid 2,5-dioxo-pyrrolidin-1-yl ester. Grades: Highly Purified. CAS No. 89889-52-1. Pack Sizes: 10mg, 25mg, 50mg, 100mg, 250mg. Molecular Formula: C26H41N5O7S. US Biological Life Sciences. | Worldwide |
| Succinimidyl 6-(biotinamido)hexanoate | Succinimidyl 6-(biotinamido)hexanoate. Group: Polymers. CAS No. 72040-63-2. Product ID: (2,5-dioxopyrrolidin-1-yl) 6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoate. Molecular formula: 454.5g/mol. Mole weight: C20H30N4O6S. C1CC (=O)N (C1=O)OC (=O)CCCCCNC (=O)CCCCC2C3C (CS2)NC (=O)N3. InChI=1S/C20H30N4O6S/c25-15 (7-4-3-6-14-19-13 (12-31-14)22-20 (29)23-19)21-11-5-1-2-8-18 (28)30-24-16 (26)9-10-17 (24)27/h13-14, 19H, 1-12H2, (H, 21, 25) (H2, 22, 23, 29)/t13-, 14-, 19-/m0/s1. UVGHPGOONBRLCX-NJSLBKSFSA-N. |  |
| Succinimidyl-6-(biotinamido) Hexanoate | Succinimidyl-6-(biotinamido) Hexanoate. Pack Sizes: Milligram Quantities: 100 mg. Order Number: B104. | www.prochemonline.com |
| Succinimidyl-6-(bromoacetamido)caproate | Succinimidyl-6-(bromoacetamido)caproate. CAS No. 109880-16-2. Molecular formula: C12H17BrN2O5. Catalog: ACM109880162. | |
| Succinimidyl-6- (iodoacetyl) aminocaproate | Succinimidyl-6- (iodoacetyl) aminocaproate. Group: Biochemicals. Alternative Names: SIAX. Grades: Highly Purified. CAS No. 134759-23-2. Pack Sizes: 10mg, 25mg, 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-6- (iodoacetyl) aminocaproate 98+% (HPLC) | Succinimidyl-6- (iodoacetyl) aminocaproate 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg, 100mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-7-amino-4-methylcoumarin-3-acetate | Succinimidyl-7-amino-4-methylcoumarin-3-acetate. CAS No. 113721-87-2. Pack Sizes: Milligram Quantities: 50 mg. Order Number: M107. | www.prochemonline.com |
| Succinimidyl Acetate | Succinimidyl Acetate (CAS# 14464-29-0) is a useful research chemical. Synonyms: Succinimidylacetate; N-Acetoxysuccinimide; 2,5-Dioxopyrrolidin-1-ylacetate; 1-(Acetoxy)pyrrolidine-2,5-dione; Succinimide,N-acetoxy-; N-acetoxy-succinimide; 2,5-Pyrrolidinedione, 1-(acetyloxy)-; N-acetoxyphthalmide; acetic acid succinimidyl ester; Acetic Acid N-Succinimidyl Ester; N-Succinimidyl Acetate; acetic acid N-hydroxysuccinimide ester; acetic acid N-hydroxysuccinimidyl ester; acetyl N-hydroxysuccinimide ester; N-Acetoxy-phthalimide; AC-OSu. Grades: 95 %. CAS No. 14464-29-0. Molecular formula: C6H7NO4. Mole weight: 157.12. | |
| Succinimidyl acridine-9-carboxylate | Succinimidyl acridine-9-carboxylate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl acridine-9-carboxylate 98+% (HPLC) | Succinimidyl acridine-9-carboxylate 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl bromoacetate ≥97% (NMR) | Succinimidyl bromoacetate ≥97% (NMR). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 1g, 5g. US Biological Life Sciences. | Worldwide |
| Succinimidyl Glutaramide-PEG5K-Succinimidyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| Succinimidyl iodoacetate 98+% (HPLC) | Succinimidyl iodoacetate 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg, 250mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl Myristate | Succinimidyl Myristate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1g. US Biological Life Sciences. | Worldwide |
| Succinimidyl Nervonate | Succinimidyl Nervonate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl N-methylanthranilate | Succinimidyl N-methylanthranilate is an amine-reactive probe. Synonyms: 2,5-Pyrrolidinedione, 1-((2-(methyl)amino)benzoyl)oxy. CAS No. 64156-72-5. Molecular formula: C12H12N2O4. Mole weight: 248.24. | |
| Succinimidyl oxycarbonyl -b-alanine- hydroxysuccinimide ester 99+% (NMR) | Succinimidyl oxycarbonyl -b-alanine- hydroxysuccinimide ester 99+% (NMR). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 250mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl oxycarbonyl -beta-alanine- hydroxysuccinimide ester | Succinimidyl oxycarbonyl -beta-alanine- hydroxysuccinimide ester. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 50mg, 100mg, 250mg. US Biological Life Sciences. | Worldwide |
| Succinimidyl-p-formylbenzoate 98+% (HPLC) | Succinimidyl-p-formylbenzoate 98+% (HPLC). Group: Biochemicals. Grades: Reagent Grade. Pack Sizes: 100mg, 250mg, 1g. US Biological Life Sciences. | Worldwide |
| Succinimidyl Succinamide-PEG5K-Succinimidyl Succinamide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 5000. | |
| 11-Maleimidoundecanoic acid sulfo-N-succinimidyl ester | 11-Maleimidoundecanoic acid sulfo-N-succinimidyl ester. Group: Biochemicals. Alternative Names: 2,5-Dihydro-2,5-dioxo-1H-pyrrole-1-undecanoic acid 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester sodium salt. Grades: Highly Purified. CAS No. 211236-68-9. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C19H25N2O9SNa. US Biological Life Sciences. | Worldwide |
| 11-Maleimidoundecanoic acid sulfo-N-succinimidyl ester | 11-Maleimidoundecanoic acid sulfo-N-succinimidyl ester. Group: Crosslinkers. Alternative Names: 2,5-Dihydro-2,5-dioxo-1H-pyrrole-1-undecanoic Acid 2,5-Dioxo-3-sulfo-1-pyrrolidinyl Ester Sodium Salt. CAS No. 211236-68-9. Product ID: sodium; 1-[11-(2,5-dioxopyrrol-1-yl)undecanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate. Molecular formula: 480.5g/mol. Mole weight: C19H25N2NaO9S. C1C (C (=O)N (C1=O)OC (=O)CCCCCCCCCCN2C (=O)C=CC2=O)S (=O) (=O)[O-]. [Na+]. InChI=1S/C19H26N2O9S. Na/c22-15-10-11-16 (23)20 (15)12-8-6-4-2-1-3-5-7-9-18 (25)30-21-17 (24)13-14 (19 (21)26)31 (27, 28)29; /h10-11, 14H, 1-9, 12-13H2, (H, 27, 28, 29); /q; +1/p-1. MKNJJMHQBYVHRS-UHFFFAOYSA-M. | |
| 11- (Succinimidyloxy) Undecyldimethylethoxysilane | Silsesquioxane and Organosilicone. CAS No. 1274903-20-6. Molecular formula: C19H37NO4Si. Mole weight: 371.59 g/mol. Catalog: ACM1274903206. | |
| 3- (2-Pyridyldithio) propionic acid N-succinimidyl ester | 3- (2-Pyridyldithio) propionic acid N-succinimidyl ester. Group: Biochemicals. Alternative Names: SPDP. Grades: Highly Purified. CAS No. 68181-17-9. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C12H12N2O4S2. US Biological Life Sciences. | Worldwide |
| 3- (2-Pyridyldithio) propionic Acid N-Succinimidyl Ester (SPDP) | A heterobifunctional cross-linker. Group: Biochemicals. Alternative Names: SPDP. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| 3β-Amino-3-Deoxydigoxigenin Hemisuccinamide Succinimidyl Ester | 3β-Amino-3-Deoxydigoxigenin Hemisuccinamide Succinimidyl Ester is an amine-reactive derivative of Digoxigenin. It has been shown to inhibit the Na+/K+ ATPase by binding to the cardiac steroid receptor site. Synonyms: 3β-Amino-3-deoxydigitoxigenin Hemisuccinate N-Succinimidyl Ester; (3β,5β,12β)-3-[[4-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-1,4-dioxobutyl]amino]-12,14-dihydroxycard-20(22)-enolide. CAS No. 216299-46-6. Molecular formula: C31H42N2O9. Mole weight: 586.67. | |
| 3-Maleimidobenzoic acid succinimidyl ester | 3-Maleimidobenzoic acid succinimidyl ester is a heterobifunctional crosslinking reagent reactive toward primary amine and sulfhydryl. Synonyms: 3-maleimidobenzoic acid N-hydroxysuccinimide; MBS; Succinimidylmaleimidobenzoate; m-maleimimidobenzoyl-N-hydroxysuccinamide ester; 3-MaleiMidobenzoic acid-NHS ester; 2,5-dioxopyrrolidin-1-yl 3-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate; MBS;N-Hydroxy-succinimidyl 3-maleimido-benzoate; 1- (3- ( ( (2, 5-Dioxopyrrolidinyl) oxy) carbonyl) phenyl) -1H-pyrrole-2, 5-dione; m-MALEIMIDOBENZOYL-N-HYDROXYSUCCINIMIDE ESTER; 3-N-Maleimidobenzoic Acid N-Succinimidyl Ester; m-MBS; SCHEMBL79589. Grades: 95% (HPLC). CAS No. 58626-38-3. Molecular formula: C15H10N2O6. Mole weight: 314.25. | |
| 3-Maleimidopropionic acid N-succinimidyl ester | 3-Maleimidopropionic acid N-succinimidyl ester. Group: Biochemicals. Alternative Names: 2,5-Dihydro-2,5-dioxo-1H-pyrrole-1-propanoic acid 2,5-dioxo-1-pyrrolidinyl ester; 3-Maleimidopropionic acid N-hydroxysuccinimide ester; N-Succinimidyl 3-(N-maleimido)propionate. Grades: Highly Purified. CAS No. 55750-62-4. Pack Sizes: 1g, 2g, 5g, 10g, 25g. Molecular Formula: C11H10N2O6. US Biological Life Sciences. | Worldwide |
| 3-N-Maleimidobenzoic acid N-succinimidyl ester | 3-N-Maleimidobenzoic acid N-succinimidyl ester. Group: Biochemicals. Alternative Names: 3-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)benzoic acid 2,5-dioxo-1-pyrrolidinyl ester; m-Maleimidobenzoyl-N-hydroxysuccinimide; NSC 294786. Grades: Highly Purified. CAS No. 58626-38-3. Pack Sizes: 50mg, 100mg, 250mg, 500mg, 1g. Molecular Formula: C15H10N2O6. US Biological Life Sciences. | Worldwide |
| [ (3R, 3aS, 6aR) -Hydroxyhexahydrofuro [2, 3-b]furanyl Succinimidyl Carbonate | Darunavir intermediate. Group: Biochemicals. Alternative Names: Carbonic Acid 2,5-Dioxo-1-pyrrolidinyl [(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl] Ester; 1-[[[[(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl]oxy]carbonyl]oxy]-. Grades: Highly Purified. CAS No. 253265-97-3. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| 4- (4- (Dimethylamino) phenylazo) benzoic acid N-succinimidyl ester | 4- (4- (Dimethylamino) phenylazo) benzoic acid N-succinimidyl ester. Group: Biochemicals. Grades: Highly Purified. CAS No. 146998-31-4. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C19H18N4O4. US Biological Life Sciences. | Worldwide |
| 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester | 4, 7, 10, 13, 16, 19, 22, 25, 32, 35, 38, 41, 44, 47, 50, 53-Hexadecaoxa-28, 29-dithiahexapentacontanedioic acid di-N-succinimidyl ester. Group: Poly(ethylene glycol) and poly(ethylene oxide). CAS No. 947601-98-1. Product ID: (2,5-dioxopyrrolidin-1-yl) 3- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [2- [3- (2, 5-dioxopyrrolidin-1-yl) oxy-3-oxopropoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethyldisulfanyl] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] ethoxy] propanoate. Molecular formula: 1109.3g/mol. Mole weight: C46H80N2O24S2. C1CC (= O) N (C1= O) OC (= O) CCOCCO CCOCCOCCOCCOCCOCCOCCSSCCOCCOCCOCCOCC OCCOCCOCCOCCC (= O) ON2C (= O) CCC2= O. InChI= 1S / C46H80N2O24S2 / c49-41-1-2-42 (50) 47 (41) 71-45 (53) 5-7-55-9-11-57-13-15-59-17-19-61-21-2 3-63-25-27-65-29-31-67-33-35-69-37-39 -73-74-40-38-70-36-34-68-32-30-66-28- 26-64-24-22-62-20-18-60-16-14-58-12-1 0-56-8-6-46 (54) 72-48-43 (51) 3-4-44 (48) 52 / h1-40H2. CIAGMHUFXZNZOO-UHFFFAOYSA-N. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester, 4arm-PEG-SCM. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 10000. | |
| 4arm-PEG10K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 10000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Carboxymethyl Glutaramide | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Glutaramide. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 20000. | |
| 4arm-PEG20K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 20000. | |
| 4arm-PEG40K-Succinimidyl Carboxymethyl Ester | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Carboxymethyl Ester. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Glutarate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Glutarate. Molecular formula: average Mn 40000. | |
| 4arm-PEG40K-Succinimidyl Succinate | Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 4arm-PEG-Succinimidyl Succinate. Molecular formula: average Mn 40000. | |
Our database is helping our users find suppliers everyday.
